ASDAS-CRP and ASDAS-ESR cut-offs for disease activity states in axial spondyloarthritis – Are they interchangeable?

Stylianos Georgiadis,Lykke Midtbøll Ørnbjerg,Brigitte Michelsen,Tore K. Kvien,Daniela Di Giuseppe,Johan K. Wallman,Jakub Závada,Sella A. Provan,Eirik Klami Kristianslund,Ana Maria Rodrigues,Maria José Santos,Žiga Rotar,Katja Perdan Pirkmajer,Dan Nordström,Gary J. Macfarlane,Gareth T. Jones,Irene van der Horst-Bruinsma,Pasoon Hellamand,Mikkel Østergaard,Merete Lund Hetland
DOI: https://doi.org/10.3899/jrheum.2023-1217
2024-04-15
The Journal of Rheumatology
Abstract:Objective Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) is recommended over erythrocyte sedimentation rate (ASDAS-ESR) to assess disease activity in axial spondyloarthritis (axSpA). Although ASDAS-CRP and ASDAS-ESR are not interchangeable, the same disease activity cut-offs are used for both. We aimed to estimate optimal ASDAS-ESR values corresponding to the established ASDAS-CRP cut-offs (1.3, 2.1 and 3.5) and investigate the potential improvement of level of agreement between ASDAS-ESR and ASDAS-CRP disease activity states when applying these estimated cut-offs. Methods We used data from axSpA patients initiating a tumour necrosis factor inhibitor from nine European registries. ASDAS-ESR cut-offs were estimated using the Youden index. Level of agreement between ASDAS-ESR and ASDAS-CRP disease activity states was compared against each other. Results In 3,664 patients, mean ASDAS-CRP was higher than ASDAS-ESR at both baseline (3.6 and 3.4, respectively) and aggregated follow-up at 6, 12, or 24 months (1.9 and 1.8, respectively). The estimated ASDAS-ESR values corresponding to the established ASDAS-CRP cut-offs were 1.4, 1.9 and 3.3. By applying these cut-offs, the proportion of discordance between disease activity states according to ASDAS-ESR and ASDAS-CRP decreased from 22.93% to 19.81% in baseline data but increased from 27.17% to 28.94% in follow-up data. Conclusion We estimated the optimal ASDAS-ESR values corresponding to the established ASDAS-CRP cut-off values. However, applying the estimated cut-offs did not increase the level of agreement between ASDAS-ESR and ASDAS-CRP disease activity states to a relevant degree. Our findings did not provide evidence to reject the established cut-off values for ASDAS-ESR.
rheumatology
What problem does this paper attempt to address?